Lv7
3320 积分 2024-06-01 加入
Propensity Score-Matched analysis supports the survival benefits of combination chimeric antigen receptor T-cell therapy with autologous transplantation in relapsed or refractory diffuse large B-cell lymphoma: Insights from a real-world study in China
20小时前
待确认
Propensity Score-Matched Analysis Supports the Survival Benefits of Combination Chimeric Antigen Receptor T-Cell Therapy with Autologous Transplantation in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Insights from a Real-World Study in China
1个月前
已完结
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy
3个月前
已完结
Cytokine Release Syndrome with Chimeric Antigen Receptor T Cell Therapy
3个月前
已完结
Siltuximab for chimeric antigen receptor T-cell therapy–related CRS and ICANS: a multicenter retrospective analysis
3个月前
已完结
IL-6 Blockade in Cytokine Storm Syndromes
3个月前
已完结
Targeting signaling pathways in lymphoma: From molecular mechanisms to clinical breakthroughs
3个月前
已完结
LAMP1 Overexpression Predicts for Poor Prognosis in Diffuse Large B-cell Lymphoma
4个月前
已关闭
<p>Ibrutinib in Chronic Lymphocytic Leukemia: Clinical Applications, Drug Resistance, and Prospects</p>
4个月前
已完结
皖公网安备34019202002308
